Trelleborg Medical Solutions is significantly expanding its Innovation Center in Minnesota to undertake additional projects and accelerate the design and development cycle for customers.

The Innovation Center, currently in Plymouth, will concurrently move to a new purpose-built space in nearby Delano comprising more than 45,000 square feet (4,181 square meters).

“We know that speed to market and high quality, reliable supply are critical factors in our customer partnerships. This investment enables Trelleborg to deliver on all aspects and provide an exceptional experience to our customers from early stage prototyping all the way to high-volume commercialization, all under one roof,” said Kevin Ehlert, business unit president of Medical Device Solutions Americas.

The project involves remodeling the tool shop and room, which will expand its footprint to 6,000 square feet (557 square meters). It also includes nearly 40,000 square feet (3,716 square meters) of new construction housing a visitor center, additional high-end Swiss machining, injection molding, and increased automation laboratory space.  

“The visitor center will be a collaborative, high-tech meeting area where customers can brainstorm on project ideas alongside our experts,” stated Chris Tellers, Innovation Center and new product development director. “The additional Swiss machining and injection molding will enhance our in-house capabilities to provide the highest quality components fast without relying on outside shops.”

The Innovation Center move and expansion project is scheduled to start next spring and be completed in early 2027.

“The increased automation space provides scalability to support future projects,” Tellers continued. “We continually hear from customers that they choose us for our expertise in tooling, technical solutions and ability to assist with everything from prototyping to serial production enhanced with automation. This remodel and expansion project enables us to continue doing that but on a larger scale, utilizing more equipment and experts added through our new apprenticeship program.”

Trelleborg Medical Solutions partners with medical device​ and biopharmaceutical companies, collaborating from concept to commercialization to bring to market impactful solutions. It leverages decades of design and manufacturing experience, in-depth knowledge of polymer materials, and a deep understanding of customer applications and end-use environments to deliver engineered solutions for transformative health technologies.

Trelleborg leverages in-depth materials and applications expertise with early market insights, making the Group a worldwide developer of engineered polymer solutions. The company offers a portfolio covering various applications. Trelleborg Group reported SEK 34 billion in 2024 sales generated by operations in around 40 countries. The Group comprises three business areas: Trelleborg Industrial Solutions, Trelleborg Medical Solutions, and Trelleborg Sealing Solutions. The Trelleborg share has been listed on the Stock Exchange since 1964 and is traded on Nasdaq Stockholm, Large Cap.